Invasive aspergillosis is a rare but serious complication that can occur in solid-organ transplant recipients. This condition arises from an infection caused by Aspergillus, a widespread mold typically transmitted through the inhalation of its spores (conidia). This report presents 3 unique cases of invasive aspergillosis in patients who received either kidney or liver transplants from a 17-year-old deceased pediatric donor. The first case was a 27-yearold male kidney transplant recipient who developed symptoms at posttransplant day 65, leading to graft nephrectomy despite antifungal therapy. The second case, a 17-year-old male kidney transplant recipient with a posttransplant course similar to the first case, also required nephrectomy due to worsening invasive aspergillosis. The third case involved a 28-year-old female liver transplant recipient who presented with symptoms at posttransplant day 45 but recovered without the need for graft explant. The occurrence of Aspergillus in graft organs is generally rare and is often associated with systemic hematogenous dissemination before transplant. Clinicians should maintain a high index of suspicion for invasive mycotic infections in solid-organ transplant recipients, especially for patients who present with clump-like lesions on diagnostic imaging. Such awareness is crucial for timely diagnosis and management and may thereby potentially improve patient outcomes in this vulnerable population.

Download full-text PDF

Source
http://dx.doi.org/10.6002/ect.pedsymp2024.O4DOI Listing

Publication Analysis

Top Keywords

invasive aspergillosis
16
transplant recipients
12
transplant recipient
12
kidney liver
8
liver transplant
8
pediatric donor
8
solid-organ transplant
8
male kidney
8
kidney transplant
8
symptoms posttransplant
8

Similar Publications

Chronic granulomatous disease (CGD) is a congenital disorder impairing phagocyte function, causing recurrent, life-threatening infections, and is rarely seen in adulthood. We present a 36-year-old male initially diagnosed with pneumonia. Bronchoalveolar lavage and blood cultures yielded complex, sputum cultures .

View Article and Find Full Text PDF

spp. are ubiquitous, and people are frequently exposed to their spores in the environment and hospital settings. Despite frequent inhalation of the spores, infection is infrequent in humans, except in immunosuppressed hosts.

View Article and Find Full Text PDF

Fungal infection in patients treated with Bruton's Tyrosine Kinase inhibitor, from epidemiology to clinical outcome: A systematic review.

Clin Microbiol Infect

December 2024

Sorbonne Université, CIMI-Paris, AP-HP, Service de Parasitologie-Mycologie, Hopital de La Pitie-Salpetriere, F-75013 Paris, France. Electronic address:

Background: Bruton Tyrosine Kinase inhibitor (BTKi) emerged as key treatment for B-cell lymphomas. Despite its efficacy in the treatment of malignancies, numerous cases of invasive fungal infections (IFI) have been reported in patients receiving ibrutinib, a first generation BTKi. Cases of invasive aspergillosis have also been reported with acalabrutinib and zanubrutinib.

View Article and Find Full Text PDF

A 12-year-old terrier was referred for investigation of a 4-month history of coughing, sneezing and nasal discharge. Clinical findings were consistent with sinonasal Aspergillus fumigatus infection with evidence of intracranial extension on computed tomography. Endoscopic debridement followed by topical clotrimazole and systemic antifungal therapy resulted in clinical improvement.

View Article and Find Full Text PDF

Aim: To assess the impact of Aspergillus PCR on managing invasive aspergillosis (IA) in routine patient management.

Methods: A retrospective study included 235 patients who had Aspergillus PCR tests performed on respiratory samples (bronchoalveolar lavage, non-bronchoscopic lavage, and sputum) from November 2020 to April 2022.

Results: Of 293 tests, 11.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!